Table 5.

Characteristics of cases with CTNNB1 mutations.

Tumor Type	(n)
Endometrioid carcinoma	17 (23.3%)
Grade 1	9 (33.3%)
Grade 2	3 (12.5%)
Grade 3	5 (22.7%)
Serous carcinoma	0 (0%)
Clear cell carcinoma	1 (16.7%)
De-differentiated carcinoma	1 (12.5%)